Bris­tol My­ers Squibb com­mits $300 mil­lion to com­bat racial dis­par­i­ties, but de­clines to re­lease own de­mo­graph­ic da­ta

Af­ter the po­lice killing of George Floyd, a flur­ry of phar­ma and biotech com­pa­nies, ex­ec­u­tives and in­vestors jumped out to make state­ments, ei­ther ex­press­ing sup­port for Black Lives Mat­ter and the protests or con­demn­ing sys­temic racism.

Now, a Big Phar­ma com­pa­ny is pub­licly putting some teeth be­hind those state­ments. This morn­ing, Bris­tol My­ers Squibb an­nounced they would spend $300 mil­lion on a broad ef­fort to re­duce racial health dis­par­i­ties, and di­ver­si­fy both their clin­i­cal tri­als and their own ex­ec­u­tive team and work­force.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER